• HC Surgical appointed as the consultancy service provider for The Prestige Hospital Co., Ltd. (“TPH”) endoscopy centre
  • HCSS to provide certain exclusive medical services in TPH for a period of 3 years
  • Anticipate to generate recurring revenue stream for HCSS

Catalist-listed HC Surgical Specialists Limited (SGX:1B1) is pleased to announce that it has today, entered into an exclusive agreement (“Agreement”) with The Prestige Hospital Co., Ltd. (“TPH”), a company incorporated in Cambodia, which is valid for a term of 3 years upon commencement of the operations of the endoscopy centre, which is estimated to be on 1 March 2020 or such later date as may be agreed to in writing between both parties.

Chief Executive Officer of HCSS, Dr. Heah Sieu Min commented, “We are extremely exhilarated and look forth to our exclusive collaboration with The Prestige Hospital as it marks our maiden foray into Cambodia which is a new market for us. We see this opportunity as a testament to our medical expertise and capabilities, which is in line with our growth strategy to fortify our presence in the region. We are on track with our expansion plans and will continue to keep a lookout for other potential synergistic collaborations locally and regionally.”

Download Press Release (Full)

  • Steady Revenue growth of 25.6% in 3Q2020
  • Cash position remains robust, cash and cash equivalents increased by RM45.1 million to RM341.2 million in 3Q2020
  • Announced Capital Reduction exercise plan to improve shareholders’ return on equity

GEM COMM SGX Mainboard listed Duty Free International Limited (SGX: 5SO), the largest multi-channel duty free and duty paid retail group in Malaysia with strategic locations across Peninsular Malaysia, today announced its financial results for its third quarter (“3Q2020”) and nine months (“9M2020”) ended 30 November 2019.

Business Outlook
During the fiscal quarter, the Group proposed to undertake a Capital Reduction exercise to return to shareholders its surplus capital through a cash distribution of S$0.035 for each ordinary share in the share capital of the Group held by its shareholders. The Group plans to seek shareholders’ approval for the Capital Reduction exercise at Extraordinary General Meeting which will be convened on a later date. Against the backdrop of the increasingly competitive business environment and current economic condition of foreign currencies volatility, particularly the Ringgit Malaysia against the US Dollar, the Group anticipates its business to remain challenging for the remaining quarter of FY2020. The Group will continue its efforts to enhance its operational efficiency including stringent cost control measures while concurrently implementing several initiatives to widen its customer base in order to remain competitive in the retail industry. 

Download Press Release (Full)

  • Revenue increased 15.3% to S$9.8 million in 6MFY2020 due to contributions from its new and existing subsidiaries
  • Declared a higher interim dividend Y-O-Y at S$0.013 per ordinary share

Catalist-listed HC Surgical Specialists Limited (SGX:1B1) today announced its financial results for the three months ended 30 November 2019 (“2QFY2020”) and half-year ended 30 November 2019 (“6MFY2020”).

Annotating on the Group’s 2QFY2020 and 6MFY2020 results, Chief Executive Officer of HCSS, Dr. Heah Sieu Min said, “We have a steady growth that allows expansion to continue. We have made positive financial and operational progress during the period, including an improved revenue and profit trend. As part of our commitment to enhance shareholders’ value, we have raised our interim dividend by 30% to S$0.013 per ordinary share, which is in line with our improved core operational performance.”

Dr. Heah Sieu Min added, “The Group continues to seize good opportunities to accelerate the company’s strategy which will continue to be reviewed on a regular and disciplined basis – expanding our clinic locations and nurturing the next generation of doctors to provide quality accessible healthcare to your doorstep.”

Download Press Release (Full)

  • This strategic collaboration enables Alliance Healthcare to tap into Inova Care’s extensive regional network
  • Alliance Healthcare to support Inova Care’s growth in Singapore as its exclusive provider of health network and administrative services

Alliance Healthcare Group Limited (SGX: MIJ) is pleased to announce that one of its wholly owned subsidiaries, Alliance MediNet Pte Ltd (“Alliance MediNet”), has entered into a regional collaboration agreement with Inova Care Limited (“Inova Care”) to explore regional health and dental benefit administration opportunities.

Executive Chairman and CEO of Alliance Healthcare, Dr Barry Thng Lip Mong (唐立茂) annotated, “Today’s announcement with Inova Care is another solid step in our journey to build up our regional presence. This collaboration with Inova Care marks an important milestone for Alliance Healthcare, as we tap on Inova Care’s extensive network to expand our cashless managed healthcare service coverage for our clients in the region. As Inova Care’s exclusive partner, we look forward to supporting their growth in Singapore while expanding our clientele base locally.”

Download Press Release (Full)

  • One of two successful applicants to provide managed healthcare solutions to major healthcare institutions for a period of two years
  • Alliance Healthcare to deliver outpatient medical and/or dental clinic services to an estimate of more than 80,000 individuals comprising employees of healthcare institutions and their dependants

Alliance Healthcare Group Limited (SGX: MIJ), is pleased to announce that the Group is one of two successful applicants which has been awarded a contract by way of public tender to provide managed healthcare solutions to 38 companies (the “Entities”). The Group has signed a master services agreement with ALPS Pte. Ltd. (the “Agent”), which is acting for and on behalf of each of the Entities, to provide managed healthcare solutions for the employees of the Entities and their dependants. The Entities include major healthcare institutions, such as Changi General Hospital, KK Women’s and Children’s Hospital, Singapore General Hospital and National Health Group Polyclinics.

Executive Chairman and CEO of Alliance Healthcare, Dr Barry Thng Lip Mong (唐立茂) commented, “We are honoured that Alliance Healthcare is one of only two successful applicants to be awarded the contract to provide managed healthcare solutions to the major healthcare institutions. This is a testament to our position as one of the leading managed healthcare service providers in Singapore, as we continue to strive to assist corporates manage the challenge of rising healthcare costs.”

Download Press Release (Full)